v3.25.2
Segments - Schedule of Consolidated Condensed Financial Statements of Operating Segment (Details) - Operating Segments [Member] - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Schedule of Consolidated Condensed Financial Statements of Operating Segment [Line Items]    
Government grant revenue $ 25
Operating expenses:    
Research personnel compensation costs, including stock-based compensation 338 433
CRO and regulatory costs 15
Administrative personnel compensation costs, including stock-based compensation 335 362
Rent and office costs 200 82
Legal and accounting costs 539 413
Other expenses [1] 12 34
Total segment expenses 1,424 1,339
Loss from operations (1,424) (1,314)
Other income (expense)    
Loss on change in the fair value of related party Tasly convertible debt (61) 4
Interest expense (including related parties amounts of $704 and $624 for the three months ended March 31, 2025 and March 31, 2024, respectively) (1,230) (1,080)
Other income (1) 5
Total other expense, net (1,292) (1,071)
Net loss and comprehensive loss $ (2,716) $ (2,385)
[1] Other expenses includes small balances of research materials and supplies along with insurance costs.